Analyst Reco. Ocugen, Inc.

Equities

OCGN

US67577C1053

Market Closed - Nasdaq Other stock markets 01:30:00 01/05/2024 am IST			5-day change	1st Jan Change
1.32 ^USD	-5.04%		+5.60%	+129.57%

29/04	Ocugen, Inc. Announces Ocu400 Modifier Gene Therapy Phase 1/2 Data Presentation At Retinal Cell and Gene Therapy Innovation Summit 2024	CI
22/04	Chardan Adjusts Price Target on Ocugen to $5 From $4, Maintains Buy Rating	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Chardan Adjusts Price Target on Ocugen to $5 From $4, Maintains Buy Rating	22/04	MT
Chardan Raises Price Target on Ocugen to $5 From $4, Keeps Buy Rating	22/04	MT
HC Wainwright Adjusts Price Target on Ocugen to $7 From $5, Maintains Buy Rating	24/01	MT
Cantor Fitzgerald Adjusts Ocugen's Price Target to $2 From $2.50, Keeps Overweight Rating	31/23/31	MT
Chardan Research Raises Ocugen's Price Target to $4 From $3.50, Buy Rating Kept	08/23/08	MT
Chardan Upgrades Ocugen to Buy From Neutral, Citing Recent Sell-Off	01/23/01	MT
Mizuho Adjusts Price Target on Ocugen to $3 From $5, Maintains Buy Rating	01/23/01	MT
Mizuho Securities Starts Ocugen at Buy With $5 Price Target	23/22/23	MT
HC Wainwright Adjusts Ocugen's Price Target to $6 from $7, Maintains Buy Rating	15/22/15	MT
Roth Capital Reinstates Ocugen at Buy with $8 Price Target	15/22/15	MT
Cantor Fitzgerald Starts Ocugen at Overweight With $4.50 Price Target	02/22/02	MT
Chardan Trims Ocugen's Price Targe to $3.50 From $4, Maintains Neutral Rating	09/22/09	MT
Chardan Research Adjusts Ocugen's Price Target to $3.50 From $4, Maintains Neutral Rating	09/22/09	MT
HC Wainwright Adjusts Ocugen's Price Target to $8 from $10, Maintains Buy Rating	28/22/28	MT
ANALYST RECOMMENDATIONS : Alliant Energy, Ally Financial, Alphabet, HSBC, Honest...	14/21/14
OCUGEN : Cantor Fitzgerald Adjusts Ocugen PT to $4 From $11, Maintains Neutral Rating	11/21/11	MT
OCUGEN : Chardan Adjusts Ocugen PT to $4.50 From $8, Maintains Neutral Rating	11/21/11	MT
OCUGEN : HC Wainwright Adjusts Ocugen's Price Target to $10 From $12, Maintains Buy Rating	11/21/11	MT
OCUGEN : Roth Capital Cuts Ocugen to Neutral From Buy, Price Target to $6 From $10	11/21/11	MT
OCUGEN : Chardan Adjusts Price Target on Ocugen to $8 From $13, Maintains Neutral Rating	10/21/10	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Ocugen, Inc.

Equities

OCGN

US67577C1053

Analyst Reco.

Filters